CRISPR-based technology is advancing rapidly, driving international competition. Its promise to transform medicine is colliding with political and social realities, even as applications expand.
Promising results from a small clinical trial highlight a growing interest in designing gene-editing treatments for common ...
Scientists at St. Jude Children's Research Hospital and Northwestern University identified a previously unknown treatment ...
In a 15-patient, Phase 1 one, first-in-human trial, a one-time, CRISPR-Cas9 gene-editing therapy safely reduced LDL ...
Clustered regularly interspaced palindromic repeats(CRISPR) gene editing, known for its precision, is revolutionizing tumor research and treatment. This article covers the evolution of the CRISPR ...
Dangerously high levels of “bad” cholesterol and triglycerides may be reduced by gene editing, in what study researchers hope will be a “one and done” treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback